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Modifications in climatic conditions, movements of hosts and goods, changes in animal phenology and human
behaviour and increase of wildlife, are presently concurring in the geographic spread of vectors and cardio-respiratory
nematodes, e.g. Dirofilaria immitis, Angiostrongylus vasorum, Aelurostrongylus abstrusus and Capillaria aerophila. All these
factors may also influence dispersion and clinical significance of fleas, thus posing relevant challenges in those regions
where other parasites are emerging at the same time. Ctenocephalides felis, Ctenocephalides canis and Pulex irritans
cause discomfort, nuisance, allergic reactions, anaemia, and may transmit several pathogens, some of them are of
importance for public health. The present article reviews the importance of fleas in small animal practice and their
sanitary relevance for dogs, cats and humans, and discusses current control methods in the present era of emerging
extra-intestinal nematodes, towards a possible changing perspective for controlling key parasites affecting companion
animals.Review
Background
Cardio-respiratory nematodes affecting dogs and cats are
nowadays prevalent in several countries, where they have
a growing importance due to their clinical impact, possible
zoonotic hazard, and geographical emergence and spread-
ing in both endemic regions and areas previously free
of infection. This is the case for the mosquito-borne
Dirofilaria immitis, the mollusc-borne Angiostrongylus
vasorum and Aelurostrongylus abstrusus, and for
Capillaria aerophila, which has a direct biological cycle,
albeit earthworms may have an unclear role of facultative
intermediate or paratenic hosts [1-4]. Modifications in epi-
demiological patterns and clinical approaches for these in-
fections are changing perspective and perception on
parasitoses of pets and could lead to the fallacy that other
parasites of dogs and cats present nothing new to be in-
vestigated and disseminated. This potential mistake with
“old-fashioned” parasites has been recently discussed for
roundworms, hookworms and whipworms [5,6]. This
could be true also for ectoparasites like fleas, although
they have a major pathogenic role in human and veterin-
ary medicine. Fleas are a cause of direct damage to theCorrespondence: dtraversa@unite.it
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reproduction in any medium, provided the orhosts’ skin, they are hated by pets and owners for the nuis-
ance and distress they cause, and have a powerful vectorial
ability.
Of the more than 2,500 known fleas, three major species
feed on pets and humans [7-9]. The most widespread is
the cat flea Ctenocephalides felis (Figure 1), which is highly
prevalent in both dogs and cats in all corners of the world.
Also the dog flea Ctenocephalides canis (Figure 2) and the
human flea Pulex irritans (Figure 3) are globally distrib-
uted, although with lower rates [9,10]. These fleas have a
low degree of species-specificity, being able to infest com-
panion animals, humans and wildlife. Canine and feline
pulicosis is characterized by high infection rates every-
where [7,9,11-14], thus treatment and prevention are a
priority in veterinary medicine. However, the control
of fleas is not straightforward and requires integrated
approaches. Infected pets and environments are still a
major cause of striving for veterinarians and pet owners,
although a plethora of safe and effective products is avail-
able to be used either on the animal or in the envi-
ronment, or both.
A shift of perspective on pet parasites is occurring in
those regions where epidemiological patterns of cardio-
pulmonary nematodes are changing. In particular, veteri-
narians are often faced with the necessity of treatment
and prevention approaches controlling at the same time
both common, e.g. fleas and intestinal worms, andThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Adult Ctenocephalides felis. Figure 3 Adult Pulex irritans.
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Hence, the present review aims to provide food for
thought on control methods for fleas of pets in the
present changing era of emerging heartworms and lung-
worms. Sanitary importance of fleas, their possible
spreading, and integrated control strategies are discussed
in a comprehensive perspective.
Fleas: a threat for dogs, cats and humans
Fleas are primary ectoparasites causing discomfort, aller-
gic manifestations and anaemia, and having an efficient
vectorial ability for various pathogens. The present sec-
tion summarizes the most important pathogenic aspects
of C. felis, C. canis and P. irritans.
Biting of adult fleas is followed by a delayed reaction
and skin irritation. The lesions initially appear as single
or clustered small haemorrhagic areas. Thereby, a whealFigure 2 Adult Ctenocephalides canis.forms around each bite, with a sudden peak in few mi-
nutes and, most often, the onset of itching. The lesion
may become a hard papillar lesion [10]. Repeated expos-
ure to flea bites induces, in susceptible dogs and cats, a
condition called flea allergy dermatitis (FAD). Dogs with
FAD (Figure 4) present with erythema, alopecia, exco-
riation, papules, crusts, itching often leading to self-
traumas (Figure 5), while cats show a miliary dermatitis
(Figure 6) with nibbling, alopecia (Figure 7), intense
pruritus, licking, scratching, self-traumas [15-18]. Along
with other allergic diseases (e.g. food allergy diseases),
FAD is a major clinical entity in pets, one of the most
important skin conditions of household animals, and
one of the most frequent causes for seeking veterinary
advice [15,19].
Blood-feeding adults of Ctenocephalides spp. may cause
iron deficiency anaemia especially in puppies and kittens
[15,20]. In the case of long-lasting infections, also adult ani-
mals may suffer of blood loss and chronic anaemia [15,20].
The plague-causing bacterium Yersinia pestis circulates
in rodent populations mainly through bites of the “oriental
rat flea” Xenopsilla cheopis, which may also feed on pets
and human beings. Cats are a potential source of plague,
while dogs appear to be less susceptible to Y. pestis [9,21].
Although a correlation between human plague and
sleeping in the same bed as a dog has been documented
[22], the ability of Ctenocephalides spp. bites in transmit-
ting Y. pestis is considered low [23]. Ctenocephalides spp.
are only occasionally found on rodents and considered
unlikely bridging vectors of plague between animals and
humans [23-25]. Therefore, long and close contact with
pets and their fleas is necessary for the transmission of
plague from dogs to humans via their fleas [26]. The role
of P. irritans as a vector of plague has yet to be elucidated
[27], even though this species has been collected from ro-
dents within established plague foci and it has been
Figure 4 Localized alopecia in a dog with flea
allergic dermatitis.
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the disease [24,28].
Ctenocephalides felis can be naturally and experimen-
tally infected with Rickettsia typhi, the causative agent of
the “murine typhus”, a zoonotic disease which circulates
in rodents via the oriental rat flea [29]. Pulex irritans
has also been experimentally proved to be a vector ofFigure 5 Alopecia and self-trauma induced by biting and
scratching in a dog with flea allergic dermatitis.R. typhi, although considered unlikely to be a primary
source of the infection [30]. Cats and dogs have been
found seropositive for R. typhi in both Europe and USA
[31,32], thus they might have a certain epidemiological
role in the dispersion of this zoonosis [33]. Rickettsia
felis, a pathogen mainly transmitted by the cat flea [34]
and suspected to induce a murine typhus-like illness in
humans, is worldwide distributed, due to the global dis-
persion of C. felis, the number of infected cats and the
possibility of transstadial and transovarial transmission
in fleas [35-37]. Ctenocephalides canis and P. irritans
may also act as vectors of R. felis, and both cats and dogs
have been found harbouring this bacterium, although
their epidemiological role is yet to be fully addressed
[30,37-39].
The so-called human “cat-scratch disease” is mainly
caused by Bartonella henselae and Bartonella clarridgeiae.
Cats are their reservoirs, while dogs may be accidentally
infected by Bartonella spp., among which Bartonella
vinsonii subsp. berkhoffii is incriminated as a cause of a
human cardiac disease in tropical areas [40,41]. While cats
are recognized hosts for animal and zoonotic bartonelloses,
the role of dogs as a source of human infections is not
clearly established [42,43]. Fleas of pets are capable of har-
boring Bartonella spp. and it seems plausible that C. felis
transmits B. henselae actively. The human infection by
flea-borne Bartonella spp. generally occurs via scratches of
infected cats, whilst flea bites do not seem to play a key
role in the epidemiology of human bartonellosis. Infection
of cats by bites of infected fleas has been experimentally
demonstrated, although not considered a primary route of
transmission [30,44,45].
Fleas of pets are competent intermediate hosts of the
tapeworm Dipylidium caninum. This zoonotic cestode is
the most prevalent in dogs and cats and is often associ-
ated with pulicosis in pets, stray animals, kenneled dogs
and cats in colonies. Animals and humans become
infected by accidentally ingesting residues or whole
fleas containing the infectious cysticercoid. Indeed, D.
caninum may cause disease especially in children with
low hygiene standards [9,15].
Ctenocephalides felis, C. canis and P. irritans are inter-
mediate hosts for the filarial nematode Acanthocheilonema
reconditum, transmitted via their bites to dogs and human
beings and a cause of subcutaneous infection in animals
and ocular disease in humans [46-48].
Drivers nurturing the epidemiology of cardio-respiratory
nematodes and the dispersion of fleas: analogies and
differences
Environmental conditions, host availability and prefer-
ences, abundance and feeding behavior of vectors and
hosts are the most important drivers influencing the
geographic dissemination of helminths and arthropods
Figure 6 Flea allergic dermatitis in a cat.
Figure 7 Localized alopecia in a cat with flea allergic dermatitis
in a cat.
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parasites is associated with vector phenology and biol-
ogy, movements of goods and animals, globalization, in-
crease of wildlife in peri-urban and urban areas, and
climate changes [2,3,51].
Global warming promotes survival and reproduction
rate of arthropods and molluscs. Consequently, it may
nurture their dispersion, abundance, intensity and tem-
poral patterns throughout the year. At the same time,
climate might influence flea development and distribu-
tion, along with rates of disease transmission in urban,
suburban and rural areas. Although warmer tempera-
tures predicted in future climatic scenarios could lead
to an increased expansion of fleas, especially into the
Northern hemisphere [52], data proving whether and
how global warming is a driving force for fleas and
transmitted diseases needs to be definitively corrobo-
rated, although evidence is growing.
The use of the Geographic Information System (GIS)
and predictive models provides information for studying
the epidemiology of vectors and transmitted pathogens
[53,54]. Warmer climates and higher air temperatures
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incubation periods [2,55], as shown for D. immitis [2].
Analogously, A. vasorum is expanding, and it is expected
to increase its distribution in European regions which
offer ecological and epidemiological conditions for the ex-
pansion of current endemic areas and the establishment
of further new endemic foci [56]. At the moment no com-
puter modelling is available for the emerging respiratory
nematode of cats transmitted by snails and slugs, i.e.
A. abstrusus. However, geographic spread of gastropods,
nurtured by climate changes, may play a role in the inci-
dence and distribution of all mollusc-borne parasitoses
[57,58], including aelurostrongylosis. A. vasorum and
A. abstrusus have similar life cycles, thus the same drivers
implicated in the spread of A. vasorum would likely also
have an effect on A. abstrusus in the same areas.
Current environmental modifications could influ-
ence fleas. Thus geographical regions where cardio-
pulmonary parasites are spreading will be probably
faced also with changes in flea distribution and pat-
terns of infestation. Fleas are ectothermic arthropods
susceptible to fluctuations of temperatures, especially
because immature stages live outside the host. Indeed,
climatic variations have an impact on fleas and flea-
borne diseases because their epidemiology results from
the biological interactions between hosts, pathogens
and vectors, which are individually influenced by
temperature, humidity and precipitation.
Larval stages and pupae live within the living environ-
ment of animals, while adult fleas are permanent para-
sites, feeding on their hosts. The speed of juvenile flea
development depends on the environment, in that
higher temperatures may increase the number of gener-
ations and colder temperatures and higher humidity has
an effect on the longevity of fleas in the absence of avail-
able hosts [9]. In particular, the higher the environmen-
tal temperature, the higher the rate of development,
until a critical value is reached. Beyond this value, sur-
vival of immature stages decreases, especially in the
presence of low humidity [52]. Temperatures >35°C and
<3°C, in combination with a relative humidity <33%,
may impair flea development [59-61]. Accordingly, the
vast majority of past plague cases have been described
in those regions where average temperatures are >13°C,
with outbreaks occurring when temperature ranges
from 24°C to 27°C and a decrease of epidemic activities
at higher values [62-64]. Additionally, rainfall favours
vegetative production, increase of small-mammal popu-
lations, rat flea-infestation rates, along with soil mois-
ture, which promotes flea survival rates [65,66]. This
scenario enhances the probability of contact between in-
fectious fleas and susceptible hosts and, consequently,
of epizootic cases of plague [30,67]. As an example, epi-
zootics in prairie dogs from Montana, USA, were shownto be positively associated with precipitation and warm
days, but negatively associated with hotter days [68].
Given that warm and moist weather are factors bene-
ficial for flea development, microclimatic drivers like
temperature, rainfall, relative humidity and climate
changes in general, are expected to largely modify the
future dispersion of plague and of flea-borne disease
[69]. Studies have shown that fleas have a seasonality in
both the Northern and Southern Hemispheres, start-
ing their activity in spring or increasing from a low
base during spring and peaking in mid to late sum-
mer followed by a decline until winter [14,70-72]. Until
about fifteen years ago, cat fleas were considered to be
rarely found on pets in cold seasons [73], but the
present weather changes characterized by shorter win-
ters [74,75] may have a potential effect on flea activity
in the near future. This is particularly true because short
winters permit survival of fleas, especially in the stage of
quiescent adults inside the cocoon [73]. It is interesting
to note a recent study from Germany, which indicated
the absence of a relationship between seasons, climatic
conditions and presence of pulicosis in dogs and cats.
Above-average warm weather in summer 2003 was an
apparent cause of doubling documented flea infections,
probably because of outdoor environmental conditions
favourable for flea development. The highest infestation
rates were detected in July-October and July-September
for dogs and cats, respectively. However, fleas were also
present on animals in the remaining months of the year
although with lower rates. In this study, no statistical
differences were found in infestation patterns between
the four seasons, albeit prevalence of pulicosis in dogs
and cats was higher in the summer [11].
More attention is required to understand to what ex-
tent climatic conditions will affect the distribution of flea
and diseases in different epidemiological settings [69].
Hence, worthy of mention is the “FleaTickRisk” model,
designed in collaboration between climatologists, bio-
mathematicians and parasitologists, able to predict, on a
weekly basis, the activity and abundance of cat fleas (and
three tick species) in Europe, and the risk of disease
transmission [76]. Feeding behaviour and availability of
suitable hosts are other key factors impacting on the dis-
tribution of emerging nematodes and, possibly, of fleas.
Destruction and/or reduction of natural habitats oblige
wild animals to move into new hospitable environments,
in the suburbs and cities. The dispersion of wildlife (e.g.
feral cats, hedgehogs, opossums, raccoons, foxes, ro-
dents) increases the spreading of their pests and patho-
gens, often shared with humans and pets [77,78]. The
presence of red foxes (Vulpes vulpes) in cities and peri-
urban areas is likely concurring in causing the emer-
gence of heartworms and lungworms [1,3,79-82]. Red
foxes are common reservoirs for D. immitis in several
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in Spain and Italy [79,82]. The current trend in the
higher incidence of canine angiostrongylosis and the
concomitant expansion in foxes demonstrates that
the parasite is emerging in wild reservoirs, along with
establishment and spreading in companion dogs [4,56].
Finally, the recent finding of genetic haplotypes of C.
aerophila shared between foxes, beech martens, cats
and dogs in European countries, ultimately supports
the existence of common patterns of transmission for
respiratory nematodes between wildlife and pets [83].
Interestingly, the most recent published case of human
lung capillariosis has been recently described from
Serbia, where the infection rate of C. aerophila in foxes
is very high [84,85].
Given that flea populations are shared among domes-
tic and wild reservoirs, household dogs and cats could
be more frequently exposed to pulicosis, as for extra-
intestinal nematodes. In fact, abundance of suitable
hosts, and attractiveness and tolerance of wild animals
to flea bites, influence the survival and development of
fleas. Most fleas are generalist rather than specialist, thus
this ability makes wildlife a source for pulicosis for pets
and humans and bridging hosts for transmitted patho-
gens. Fleas infesting feral animals may be picked up by
privately owned pets and brought into homes, thus be-
coming a nuisance and potentially carrying pathogens of
human and veterinary concern [86]. Indeed, wildlife rep-
resents an “overwintering strategy” for fleas of pets, be-
cause mammals living in sub-urban and urban territories
may be infested by fleas throughout the year, thus they
are a source of infestation for cats and dogs, especially
in spring and summer [73,87]. Repeated reports of
C. felis, C. canis and P. irritans in wild animals, e.g. red
foxes [88-90], confirm that they serve a source of main-
tenance. Altogether, the susceptibility of both pets and
wildlife to the same species of fleas, lungworms and
heartworms, suggests that epidemiological interactions
play a crucial role in spreading infections in endemic
and areas previously free of infection, when suitable
bridging epidemiological settings occur. These scenarios
have a major relevance also for the dispersion of flea-
borne pathogens, as shown by the key examples from
the following.
Human dwellings in African regions endemic for plague
are considerably infested by the human-associated fleas
C. felis and X. cheopis, other than P. irritans [27,30]. Out-
breaks of murine typhus in the USA have been attributed
to the presence of infected cats and opossums, the high
number of opossums infested by C. felis, the maintenance
of R. typhi in the cat flea/opossum cycle and the avidity of
cat fleas in biting humans [35,37,91-93]. A similar situ-
ation has been described for R. felis, as shown by its pres-
ence in C. felis collected from opossums in the USA [86].Recently, B. henselae and B. clarridgeiae were detected in
cat fleas from V. vulpes in Australia and B. clarridgeiae in
the blood of a fox, thus suggesting that this wild canid
may act as a reservoir of bartonellosis for fleas, animals
and humans [94]. A study in the USA showed antibody ti-
tres for Bartonella spp. in three different felids, including
feral cats, living in sympatry along urban edges and with
degrees of contact with each other, home range and re-
source requirements [95].
Indeed, data on the natural cycle of flea-borne patho-
gens in wildlife from Europe are scanty. For example,
B. henselae has been recently found in a wildcat (Felis
silvestris) and R. felis was found in C. felis infesting wild
animals in Spain [96,97]. Also, the DNA of Bartonella
spp. and R. felis has been found in fleas biting a wood
mouse in the Netherlands [98] and in wild animals from
Germany [99]. Seropositivity for R. typhi in diffe-
rent species of wild rodents has also been detected in
Spain [100].
Fleas and cardio-pulmonary nematodes control: many
more things in common than we probably think
Treatment and prevention of fleas are necessary to re-
solve sanitary and pest problems associated with the
infestation of pets and homes, and to minimize the ex-
posure to transmitted diseases. To effectively eradicate a
flea infestation, both adult and immature stages must be
eliminated. This appears simple but owners and veteri-
narians struggle daily with fleas, because this mission
can be accomplished only with reliable and integrated
approaches, avoiding one-off methods.
The administration of insecticides on an animal
infested with existing fleas permits control of adult
stages. However, the vast majority of the flea populations
live for a long time outside the host, thus the environ-
ment is a key factor to treat pulicosis and prevent re-
infections [7,101,102]. When an infested dog or cat
moves around, thousands of eggs may roll off from the
hair onto baskets, beds, carpets, blankets, sofas, where
immatures may survive for months.
Control of fleas in the environment can be obtained by
administering parasiticide formulations acting on both
adult and immature stages to the animal, or by using
adulticides along with combinations containing chemicals
effective against environmental juveniles. Direct measures
may integrate the use of chemicals but they are not useful
alone [103]. These measures could rely on insecticidal
dusts to treat runways, burrows, pet bedding and premises
in general. Regular vacuum cleaning of carpets, blankets
and pet bedding areas reduces the contamination by
flea eggs.
Prevention in animals free of fleas may be achieved
also by residual insecticides alone and/or repellents, but
they are out of the scope of the present review and have
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only on those chemicals useful to treat and/or prevent
fleas, which are available in combination with com-
pounds used in the control of cardio-pulmonary nema-
todes of dogs and cats. Below are provided examples of
studies carried out to evaluate their efficacy in control-
ling flea infestations.
Macrocyclic lactones (MLs) belonging to the group of
avermectins/milbemycins are endectocides with a broad
spectrum of activity, including nematodes and several
arthropods. They have a GABA-mimetic effect via the
binding of glutamate-gated chloride channels. MLs may
be available in combination with insecticides/acaricides
to expand their spectrum of activity, including fleas.
Among these drugs, topical selamectin kills adult
C. felis and prevents flea eggs from hatching. Selamectin
eliminates up to 98.3% and 90.1% of newly acquired
adult fleas within 24 hours on days 21 and 28 after treat-
ment, respectively, 99.0% of fleas within 48 hours from
the infestation at 28 days after treatment, and it may
allow control of 97.3% adult fleas at 31 days after treat-
ment [105,106]. Selamectin reduces egg production, has
ovicidal effects impairing larval emergence from eggs in
days 2–37 post-treatment (hatch rate 0–13.2%) and al-
lows a 23.3% larval emergence rate at Day 45 post treat-
ment [106]. It has been suggested that debris con-
taminated with selamectin kill eggs and larvae probably
by contact and ingestion, leading to ~98% decrease
of egg production and ~92% failing in egg hatching
[107,108]. This drug can be used on a monthly basis to
treat existing pulicosis and prevent the development of
fleas in environmental conditions [109].
Neonicotinoids, spinosins and insect growth regulators
(IGRs) are common parasiticides present in formulations
also containing MLs licensed for the control of cardio-
pulmonary nematodes.
Neonicotinoids cause spastic paralysis of insects with
an agonistic effect on postsynaptic nicotinic acetylcho-
line receptors of motoneurons. Imidacloprid, one of the
most used of these chloronicotinyl compounds in both
dogs and cats, has a residual activity lasting about a
month [104]. Its efficacy relies on contact with fleas,
which die within 24 hours and sometimes between 2
and 8 hours after infestation [104,105,110]. Other than a
quick adulticidal activity against already existing infec-
tions on pets, imidacloprid presents a significant flea lar-
vicidal effect [111-113]. Single topical applications of
imidacloprid provide control and reduction of flea num-
bers of > ~95-97% on cats and dogs for 28–37 days,
and >98.6% reduction of off-host stages in premises
[114-116]. After application on the hair of a pet, suffi-
cient amounts of imidacloprid are transferred to the sur-
rounding environment (e.g. blanket) preventing a high
percentage of larvae from developing into adults atabout 1 month [113]. Larvae in the pet’s living environ-
ment are killed after contact with a treated dog or a cat,
resulting in the reduction of developing fleas and in
preventing (re-)infestation of treated animals for at least
4 weeks (e.g. highly satisfactory 36-hours flea kill rate at
27–41 days after treatment), even though with a varying
degree of decrease in the speed of kill (e.g. at Day 28
72.6% of the fleas killed within 48 hours of infection, or
at Day 34 90.8% flea reduction at 24 hours) throughout
the month following application [105,112,113,117-120].
Other than alone, this insecticide is available in com-
bination with ivermectin (e.g. in North America) and
moxidectin.
Spinosins bind nicotinic acetylcholine receptors of in-
sects, causing a stimulation of post-synaptic neurons
[104]. The efficacy is based on contact or after ingestion,
thus they are marketed in topical or oral formulation.
The compound consisting of a mixture of spinosins A
and D, i.e. spinosad, has an anti-flea efficacy starting half
an hour after oral administration and reaching 100% effi-
cacy at 4 through 48 h post-treatment against existing
infestations in dogs [121]. Its persistent efficacy against
re-infestations has been shown to last about one month,
although with a certain degree of reduction in speed of
action (i.e. speed at 4 hours of 74% and 42% after 3 and
4 weeks) and in killing efficacy against Ctenocephalides
spp. (i.e. 100% at 24 hours during three weeks, then de-
creasing until 85% and 80.4% at Day 28 and Day 43 re-
spectively) [121-124]. Spinosad, moreover, is effective in
reducing flea egg production (>99.8% for about 1 month)
although its absence in the skin debris of treated dogs
results in no effects on environmental flea stages [121].
Other than alone, this chemical is also available, at the
moment only in North America, in combination with
milbemycin oxime.
IGRs inhibit the reproduction in adult insects and
block the organogenesis of immature instars via hormo-
nal or enzymatic influence. Of the two groups of IGRs
available, i.e. juvenile hormone analogs and chitin syn-
thesis inhibitors, molecules belonging to the latter group
are available in formulations containing also MLs. Chitin
synthesis inhibitors have effects both on adult stages on
the animal and on immature fleas in the environment.
Female adult fleas suffer from a reduction of prolificacy
and fecundity, while egg hatching and larval moults are
inhibited [104]. Lufenuron, belonging to the group of
benzoyl-phenyl-ureas (BPUs) and classified as an insect
development inhibitor (IDI), is available either in inject-
able or oral formulations, the latter also containing
milbemycine oxime. Lufenuron has ovicidal and larvi-
cidal activity but no adulticidal effect [125,126]. This
molecule provides flea control on the animal and in the
environment because female fleas biting treated animals
will generate eggs from which no larvae will hatch
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environment are unable to moult to the next stage
[125,127,128]. A three-year study demonstrated that the
monthly administration per os of lufenuron to cats and
dogs is able to provide long-term reliable control of
fleas [78]. Lufenuron proved to be highly effective when
used alone in simulated home environments with in-
duced flea infestations [129-131], but a fast acting
adulticide should be also used if a flea infestation is
already established at the beginning of the treatment
[132]. A 3-months trial showed that the combined ad-
ministration of oral lufenuron once a month, and of an
insecticide at two different regimens, may reduce flea
populations on pets by at least 97.3% within one week,
maintaining this level of reduction for 90 days, along
with a highly effective control level for off-host stages
[133]. Indeed, the concomitant use of adulticides greatly
supports the elimination of adult fleas, especially within
the first 3 weeks of therapy, which is crucial especially
in situations with intense flea challenge [134]. A recent
90-day study carried out with the oral combination
containing lufenuron and milbemycin oxime showed
that no adult stages are generated from eggs laid by fleas
present on experimentally infected dogs which are
treated 30 days apart for three times [135].
Apart from selamectin, the aforementioned com-
pounds are available in formulations also containing
MLs potentially useful to control cardio-pulmonary
nematodes.
A spot-on containing imidacloprid 10%/moxidectin
2.5% can be used for preventing canine angiostrongylosis
for its effective and safe larvicidal activity in dogs experi-
mentally infected with A. vasorum. A single topical ap-
plication is 100% effective in the elimination of fourth
stage larvae (L4) and pre-adults of the parasite, thus
preventing patent infections. A monthly-based use of
this topical spot-on potentially prevents or, at least, min-
imizes the establishment of adult A. vasorum, the severe
cardiopulmonary tissue damage caused by the parasite
and the clinical onset of the disease [136]. Milbemycin
oxime is another potential option for preventing canine
angiostrongylosis because an efficacy of 85% has been
reported in dogs, which received 0.5 mg/kg of the drug
at 30 and 60 days after experimental infection with
A. vasorum [137].
MLs can be used to prevent canine heartworm disease
in both dogs and cats for their ability to kill third and
fourth larval stages of D. immitis [138]. Milbemycin ox-
ime and moxidectin can be administered in dogs once a
month during the season of activity of mosquitoes, with
the first dose given within a month after the beginning
of the season and the last dose within 1 month after
vectors disappear [138,139]. The spot-on formulation
containing imidacloprid 10%/moxidectin 1% and oralmilbemicyn oxime may be used also for the prevention
of D. immitis infection in cats [140-143]. As an example,
the imidacloprid 10%/moxidectin 1% spot-on provides
88.4-100% control of adult C. felis for 35 days in cats,
other than treatment and control of intestinal nematodes
and heartworm [143,144]. When milbemycin oxime is
associated with praziquantel the formulation can be used
also for tapeworms, and when associated with lufenuron
the combination is effective also against immature fleas
[5,6]. Topical selamectin can be used to prevent car-
dio-pulmonary dirofilariosis in dogs and cats and, as
mentioned above, this formulation is active against
fleas and other major parasites of companion animals
[107,138,139].May control of fleas support prevention of cardio-
pulmonary nematodes and vice versa?
In newly acquired infestations, the first fleas jumping
and biting on a pet are unseen and the animal remains
untreated for several days or weeks [102]. The infest-
ation is instead noticed when the animal has become
parasitized by a high number of fleas. At that time, the
untreated animal has already dispersed flea eggs in the
environment, which have given rise to larvae, pupae, and
newly emerging adult fleas. This results in an infestation
diagnosed only when the home is already contaminated
with hundreds to thousands of flea life stages, poten-
tially causing continuous re-infestations for the pet
[102,145,146].
The ideal goal is a pet free of fleas throughout the year,
regardless an existing pulicosis, and protected even
when it comes in contact with these ectoparasites. In
general, a year round approach is not applied for fleas
by pet owners and veterinarians, because control of
pulicosis is traditionally suggested from late winter or
early spring and continued throughout summer until au-
tumn. This is usually based on seasonal treatment with
formulations containing residual insecticides and/or re-
pellents [7,17,18,101,147], most of which are out of the
scope of the present article. In any case, collars are not
usually replaced more than once a year, and those with
the longest activity do not encompass 12 months; more-
over, spot-on and spray formulations are usually not ap-
plied monthly for a year by the owners. Hence, all pets
can be at risk of exposure to fleas in certain months.
This is particularly true if one considers that differences
may not exist in flea infestation patterns between the
four seasons of the year [11]. As an example, although
multicentre field trials have successfully demonstrated
the monthly efficacy of spinosad in naturally infected
dogs during the summer, i.e. the period of highest level
of contamination for homes [148], control of fleas is not
imperatively seasonal.
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ing pets is often questioned and, for instance, the US
Companion Animal Parasite Council (CAPC) and the
European Scientific Counsel Companion Animal Parasites
(ESCCAP), have different guidelines. In particular, there
has been a debate on the duration of the monthly chemo-
prophylaxis for D. immitis, i.e. if all year round, six
months, or only during the mosquito season [149-151].
Indeed, the availability of parasiticide formulations provid-
ing monthly protection from D. immitis when mosquitoes
are active and continued control of intestinal infection by
nematodes, could make the interruption of an all year
round control program undesirable. This is particularly
true where the risk of heartworm transmission is consid-
ered low but pets may be infected with intestinal ne-
matodes (e.g. whipworms, hookworms, roundworms)
throughout the year [5,6,149]. Hence, the CAPC suggests
to use broad-spectrum parasiticides year round to have a
pet free of intestinal worms, along with the prevention for
D. immitis. Such an approach could be endorsed by veteri-
narians and pet owners elsewhere because, regardless of
the ubiquitous distribution of intestinal worms [5,6],
cardio-pulmonary nematodes are spreading and/or emer-
ging in several countries of Europe [3,152], and there is a
risk of importation and establishment (A. vasorum) in the
Americas [153]. The ESCCAP has suggested extending
chemoprevention for D. immitis to 7–8 months or even
year round [2], given that certain vectors (e.g. the Asian
tiger mosquito Aedes albopictus) may survive in temperate
areas as adult stages, even during winter [154]. This mos-
quito has the potential to extend animal and human risk
of exposure to heartworms during the whole year, espe-
cially in urban habitats of southern areas [2]. Also, large-
scale and prolonged preventative measures against canine
dirofilariosis may promote a decrease in the prevalence in
those dogs living in the same area, but not subjected to
the prophylaxis. In fact, chemopreventatives reduce the
abundance of reservoirs, as shown in some areas of
Northern Italy [155], thus they could be useful in reducing
the spread of D. immitis also where the infection has
a low prevalence and/or the nematode has emerged re-
cently [2,156].
Another important example is provided by the French
heartworm A. vasorum, which is expanding in several
countries of Europe where it may overlap the distribution
of D. immitis and even cause co-infections [3,157]. Add-
itionally, this nematode also represents a potential threat
for North America, e.g. through imported infected hosts
[153]. Hence, there is the actual risk that veterinarians will
need to use chemopreventative approaches with MLs also
for canine angiostrongylosis which, at present, is suggested
in those areas with high epidemiological hazard [3,136].
In summary, several parasiticides used for the control of
intestinal nematodes and chemoprevention of D. immitisand, possibly, of A. vasorum, contain chemicals useful in
flea control programs. They add further support to the
yearly use of some products in particularly risky situa-
tions, given that domestic temperatures allow ectopara-
sites (e.g. fleas) to survive, develop and infect pets (and
sometimes owners) throughout the year [149]. There-
fore, the all-year round treatment with broad spectrum
combinations can be applied to assure treatment, pre-
vention and/or control of major parasites, including in-
testinal and cardio-pulmonary nematodes (and other
parasites, according to the formulation), especially when
immature stages of fleas should be kept under control
in the home environment.
Final remarks
Fleas are a constant danger for animal and human health
for the primary pathogenic potential they have and for
the pathogens they transmit with their blood meals or
faeces. Thus, there is a constant concern over their con-
trol in most countries of the world.
Apparent evidence that the present climate changes
and reduction in the length of winter season could
interfere in the biology of fleas in the near future is
growing. Of importance, is that fleas may survive in-
doors during the winter and also outdoors in those situ-
ations in which the environment is marginal [158]. For
instance, epidemiological changes in fleas and transmit-
ted diseases are suggested by the apparent emergence of
bartonellosis in Europe [159,160]. Also detection of
R. felis in fleas is increasing in a number of countries, thus
the distribution of this pathogen is nowadays considered
as wide as the globally distributed vector C. felis [76].
At the same time, these epidemiological changes could
contribute to “new” sanitary problems especially where in-
testinal worms are endemic and cardio-respiratory nema-
todes are spreading. Flea-borne transmitted pathogens
have been found in fleas collected in countries where
heartworms and lungworms are endemic or emerging (see
ref [3] for geographical spread of cardio-pulmonary nema-
todes in Europe). As key examples, both B. henselae and
B. clarridgeiae have been found in fleas collected from
dogs and cats in France and Germany [161], Albania
[162], Spain [90], the Netherlands [98], Hungary [163],
UK [159], and in the USA as well [164]. In Italy,
Bartonella spp. is endemic especially in the South
[165,166], where human seropositivity to cat scratch
disease has been unveiled [167]. Moreover, R. felis has
been found in cat fleas collected from companion animals
throughout the country [13,168]. At the same time Italy
is a key country for the emergence and spreading of
cardio-pulmonary nematodes, with D. immitis being
hyper-endemic in the North and expanding southward,
A. vasorum potentially spreading in all the territory, and
C. aerophila and A. abstrusus widely distributed with
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[3,56,152,169,170]. Considering that in Italy, and possibly
in other countries, intermediate and paratenic hosts of
heartworms and lungworms can be present throughout
the year [2,3], the opportunity of all-year-round controls
should be taken into account.
Control and prevention of flea infections rely on strategic
treatments with persistent adulticidal products (e.g.
imidacloprid) and/or with chemicals acting against off-host
immature stages (e.g. lufenuron) along with adulticides, if
an infestation already pre-exists [7,104,171-174]. In the
case of survival of fleas to an adulticide, and consequent
production of eggs, IGRs may ultimately prevent the devel-
opment of larvae [104,175]. This is of importance because
the efficacy of a year-long flea control program, e.g. using
monthly applications, may have some constraints if based
only on the use of residual insecticides, killing primarily
adult fleas.
Indeed, different products (e.g. imidacloprid, spinosad,
selamectin) have an excellent activity in killing existing
adult fleas on pets [104,105,114,133,172,173,176-178].
Interestingly, several studies have evaluated parasiticides
against the “KS1 cat flea strain”, which has been
maintained at the Kansas State University, USA, since
1990 and has varying levels of resistance or reduced sus-
ceptibility to different compounds [146]. However, the
susceptibility of this strain to different formulations at
varying regimens (e.g. lufenuron, spinosad, imidacloprid
+moxidectin, selamectin and others out of the scope of
this review) is clear evidence of the efficacy of com-
pounds presently marketed in controlling pulicosis for
about an entire month [135,146,179,180]. A rapid action
is also critical, because fleas should be killed as soon as
they emerge from the cocoon and jump on a pet. Adult
C. felis begins feeding almost immediately once on an
animal, with many fleas feeding within minutes [20].
The more quickly a product kills newly acquired fleas,
the more effectively it prevents FAD and reduces the
likelihood of transmission of pathogens. This is prob-
lematic, especially when client compliance with environ-
mental treatments is inconsistent, thus causing recurrent
infestations, and when residual efficacy of insecti-
cides declines after the first weeks post-administration
[181,182]. Hence, breaking the life cycle of fleas by inter-
ruption of their reproduction is crucial. Most residual flea
adulticides have a prolonged activity and they either kill or
intoxicate newly acquired fleas within one day after re-
infection [183]. Larvicidal effects of imidacloprid is of prac-
tical significance in both breaking the flea life cycle and
reducing the level of flea infestation in the domestic envir-
onment, spinosad and selamectin reduce egg production,
and the latter has ovicidal effects impairing larval emer-
gence [106,111,112,121]. Given that most insecticides may
suffer from decreasing levels of killing speed throughoutthe month following administration [105,106,123,124], en-
vironmental control is mandatory. This is even more im-
portant if one considers that rapid and voracious blood
sucking by adult fleas (e.g. 25–60% of fleas are blood fed
within 5 min and partially digested blood can be defecated
in as little as 2–6 minutes after fleas infest a host) may in-
deed impair prevention of flea biting and feeding by re-
sidual insecticides [101,184,185]. This aspect could also
have practical implications in clinical management of FAD.
A single flea is generally considered enough to elicit and
maintain the clinical signs of FAD [186], but such ability
has been recently questioned. If this dogma were true, no
flea product would provide high control against FAD, at
least not until the flea population is eradicated [101]. This
is in contrast with the evidence that residual insecticides
(among others selamectin, imidacloprid) have high efficacy
in reducing the occurrence of FAD. Therefore, it is sug-
gested that the key drivers of FAD are the degree of hyper-
sensitivity of an individual animal, the number of fleas
feeding and amount of salivary antigens injected [101].
Regardless of the role of a single flea in eliciting FAD, the
total flea eradication from the environment is necessary.
Conclusion
In conclusion, new concepts for reliable preventative
plans are presently being discussed in the scientific com-
munity, with regard to epidemiological modifications in
several areas. With ectoparasites, a correct understand-
ing of basic knowledge for the control of fleas and re-
lated diseases is important for the selection of ap-
propriate products by veterinarians. There is a constant
necessity to update practitioners on the possibilities they
have to control fleas affecting pets because they may be
not aware on the actual applicability of available formu-
lations, especially in terms of speed of kill of residual in-
secticides, ability to control feeding and reproduction of
fleas, and potential for compounds acting on off-host
immature stages [7,101]. Hence, the choice of the con-
trol method should always be made according to the
concurrent epidemiological risk not only for ubiquitous
intestinal nematodes, like Trichuris vulpis, but also for
emerging heartworms and lungworms and for the “an-
cient” fleas.
Given the new epidemiological scenarios, separate
mono-products with different target parasites would
probably be inferior if compared with a single combin-
ation able to control all major parasites at the same time,
for their a broader spectrum of activity. This is especially
true where intestinal worms and fleas are highly en-
demic and cardio-respiratory nematodes are emerging.
The high number of flea products either in combination
or as single compounds to be administered in strategic
alternations in flea control programmes is also import-
ant to minimize the risk of the onset of resistance. In
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siticides should be discouraged, given that the abuse of
anthelmintics can promote drug resistance. Actually, at
the moment there is only evidence of resistance to
pyrantel in canine hookworms. Although pyrantel is not
used for monthly prevention of cardio-pulmonary para-
sites, a high level of attention should always be main-
tained to detect any hint of resistance to parasiticides,
including MLs, in nematodes of pets. [6]. This is even
more important if one considers that there is the first la-
boratory evidence that microfilariae and third-stage lar-
vae of D. immitis can show a degree, although how
much is yet to be established, of resistance to certain
parasiticides [187].
On the other hand, further studies are warranted to ex-
tend the spectrum of activity of those formulations
containing molecules active against fleas and useful to con-
trol heartworms and lungworms. For instance, it would be
insightful to thoroughly evaluate the efficacy of ivermectin
and selamectin against A. vasorum, A. abstrusus and
C. aerophila in clinical trials, given the scant reports pub-
lished thus far [188-190]. The recent reports of the efficacy
of the spot-on formulation containing moxidectin in the
treatment of feline aelurostrongylosis and capillariosis
[169,191] should encourage further studies aiming to also
investigate the applicability of chemopreventative ap-
proaches against these parasites, as recently assessed for
dog angiostrongylosis [136]. Also, given the established ef-
ficacy of milbemycin oxime against A. vasorum [137] it
could be important to evaluate its activity in treating and
preventing C. aerophila in dogs and cats and A. abstrusus
in cats.
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